Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome
about
The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsMast Cells and Irritable Bowel Syndrome: From the Bench to the BedsideImmunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature reviewNerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal HyperpermeabilityRole of Corticotropin-releasing Factor in Gastrointestinal Permeability.Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?The role of mast cells in functional GI disorders.Not all parasites are protective.Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome.The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsThe Role of Mast Cells in Irritable Bowel Syndrome.Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome.Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators.Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner.Relation between mast cells concentration and serotonin expression in chagasic megacolon development.VIP and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis.Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome.Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study.Mucosal mast cell counts in pediatric eosinophilic gastrointestinal disease.Gastrointestinal Motility, Mucosal Mast Cell, and Intestinal Histology in Rats: Effect of Prednisone.Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients.Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study
P2860
Q26739291-3A0A4C8F-DC13-4836-B226-40E30E3FEEABQ26769635-681BA409-9EA4-4869-B3F5-9A3C51C645FDQ26795564-E9C40C38-76F8-48C3-AD97-DF5537024661Q28074635-D00D51F8-48A2-4F46-822E-DF02E5E378D3Q28079482-9384DA8C-941F-4B7D-A1CC-4EF9284CBEC7Q30421083-D43B399B-2FB7-4913-8818-60786325A83AQ33661084-A2DD7233-C1AB-40A7-9401-FA283899FBF9Q34486007-19635AFA-B1C5-4236-ADCF-CE25DC4F3076Q35429782-D1359BA3-F144-4618-BE04-2275ED7576E3Q35430640-5E5CC866-BB6A-494F-84E0-354E29A4ADE3Q35610662-6867D13D-EE43-4E21-8E4F-BD0F4A67BC19Q36207200-1301E6C4-C196-48EE-B719-6D38A8A5D06DQ37578593-0DA4F4AF-1BB7-4487-BBBC-41CB18206EDAQ38193901-FA015D49-3778-4388-A60B-24CD35B68866Q38275041-3E16ACEF-A672-46F8-B1CD-C467C5ABC8D6Q38899859-381F51F6-542D-45A5-9334-AC565B9AF6EEQ38999244-5554F982-051E-40CB-805F-ABEFEC2115BAQ39005880-357B54EA-F88B-4E85-BD2C-B3225E5E35B1Q39309675-19EA9911-2771-44F6-8D1E-CDACA0EEA977Q39311930-5FC4C675-0B01-445F-BD49-0471ED03130FQ40125277-62535A92-A281-415A-B654-C7DFF0D9B50DQ42284204-539B91CF-339D-45D9-BCC4-95CD5D2CFB0FQ43602996-BCC159DC-DE3D-433D-B867-1280B796E556Q46036841-6B47EDA0-43D2-4C5A-B8A1-F397C9DF9849Q47559834-1A77581E-0467-4C39-9390-C9239256E409Q51119801-9BEDCB86-D2B2-4274-BEA6-FD00C7049C64Q53031023-9D3E2762-D47D-47B1-8577-85BECB6CC92EQ55339881-12EF882A-1798-4FF0-A162-5844A0DE8B72Q58605500-9279021E-7C54-4AEC-96E7-41838F93A654
P2860
Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mucosal mast cell count is ass ...... inant irritable bowel syndrome
@en
type
label
Mucosal mast cell count is ass ...... inant irritable bowel syndrome
@en
prefLabel
Mucosal mast cell count is ass ...... inant irritable bowel syndrome
@en
P2093
P2860
P1476
Mucosal mast cell count is ass ...... inant irritable bowel syndrome
@en
P2093
Byung Ik Kim
Chong Il Sohn
Dong Il Park
Hong Joo Kim
Jung Ho Park
Seoung Wan Chae
Woo Kyu Jeon
Yong Kyun Cho
P2860
P304
P356
10.5056/JNM.2013.19.2.244
P50
P577
2013-04-16T00:00:00Z